LI-2242
LI-2242 is an inositol hexakisphosphate kinase (IP6K) inhibitor. LI-2242 has inhibition effect for IP6K1, IP6K2, IP6K3 and IPMK with IC50 values of 31 nM, 42 nM, 8.7 nM and 1944 nM, respectively. LI-2242 can be used for thew research of type II diabetes, obesity, metabolic complications, venous thrombosis, and psychiatric disorders[1].
Product Specifications
CAS Number
[2762762-17-2]
UNSPSC
12352005
Target
IPK Superfamily
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; PI3K/Akt/mTOR
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/li-2242.html
Purity
98.95
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2NC(C3(CCN(CC3)CC4=CC=C(C=C4Cl)Cl)C2=C1)=O)O
Molecular Formula
C20H18Cl2N2O3
Molecular Weight
405.27
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
B-Cell Antigen Receptor Complex-Associated Protein Alpha Chain (CD79A) Antibody
B-Cell Antigen Receptor Complex-Associated Protein Alpha Chain (CD79A) Antibody
Human Putative uncharacterized protein C9orf92 (C9orf92) ELISA Kit
